Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Depreciation & Amortization (CF) (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Depreciation & Amortization (CF) over the past 16 years, most recently at $1.9 million for Q2 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $1.9 million for Q2 2025, down 4.97% from a year ago — trailing twelve months through May 2025 was $8.0 million (up 0.92% YoY), and the annual figure for FY2025 was $8.0 million, up 0.92%.
  • Depreciation & Amortization (CF) for Q2 2025 was $1.9 million at Lifecore Biomedical, Inc. \De\, down from $2.1 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for LFCR hit a ceiling of $14.8 million in Q1 2021 and a floor of $1.8 million in Q4 2023.
  • Median Depreciation & Amortization (CF) over the past 5 years was $2.8 million (2022), compared with a mean of $3.7 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): skyrocketed 216.21% in 2021 and later tumbled 76.01% in 2022.
  • Lifecore Biomedical, Inc. \De\'s Depreciation & Amortization (CF) stood at $5.9 million in 2021, then tumbled by 50.41% to $2.9 million in 2022, then plummeted by 39.93% to $1.8 million in 2023, then increased by 15.74% to $2.0 million in 2024, then dropped by 6.36% to $1.9 million in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $1.9 million (Q2 2025), $2.1 million (Q1 2025), and $2.0 million (Q4 2024) per Business Quant data.